Purification of AIDS vaccine by chromatography

Purification of AIDS vaccine by chromatography

G255/0038 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 52.2MB

Downloadable file size: 5.7MB

Price image Pricing

Please login to use the price calculator

This image is part of the feature Aids Vaccine


Restrictions: Not to be shared on social media or embedded in a web page without permission.

Caption: Chromatography, one of many purification steps employed in the final stages of production of VaxSyn, an experimental AIDS vaccine. VaxSyn is based on a genetically-engineered, recombinant form of the HIV protein gp160, which is a precursor to one of HIV's surface proteins. VaxSyn contains no attenuated infectious parts of HIV & therefore carries no risk of transmitting AIDS. The vaccine is being developed by MicroGeneSys and is undergoing trials as a treatment of HIV-positive patients & as a potential vaccine against HIV infection.

Release details: Model release not available. Property release not required.

Keywords: aids vaccine, bioengineered, bioengineering, biotechnology, chromatography, drug, drugs, experimental, genetic, genetics, manufacture, production, purification, vaxsyn

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.